Printer Friendly

Ciphergen Acquires BioSepra from Invitrogen.

Carlsbad, CA and Fremont, CA 6/25/01--Ciphergen Biosystems has agreed to purchase BioSepra, S.A. from Invitrogen for approximately $12 million in cash. Paris-based BioSepra, S.A., which Invitrogen acquired when it bought Life Technologies (see IBO 7/15/00), manufactures and sells large-scale process chromatography products and had sales of around $5.9 million in 2000. Ciphergen estimates the large-scale process chromatography market at $240 million annually. With the purchase, Ciphergen plans to enter the "laboratory scale bio-separation market" through the sale of chromatography columns and media for high speed purification, disposable pre-fractionation kits for sample prep, gene to protein purification kits for tagged and non-tagged proteins, ProteinChip Systems utilizing its proprietary retentate chromatography-mass spectrometry technology for protein purification and analysis, and an expanded line of fluidized-bed process chromatography products. Ciphergen and Invitrogen also announced that they have signed a collaborative agreement to integrate their respective technologies to develop "`gene to protein' transcription, translation and protein capabilities at any scale" and "advanced `on-chip' molecular interaction and cellular assay platforms that enable functional genomics."

With this purchase, Ciphergen not only adds technology for its biochip product line but enters the process chromatography market as well. Both the expansion of its protein chip systems technology for the booming protein purification market and the partnership with Invitrogen should benefit the company. However, BioSepra's traditional marketplace is new territory for Ciphergen.
COPYRIGHT 2001 Strategic Directions International Inc. (SDI)
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Ciphergen Biosystems
Comment:Ciphergen Acquires BioSepra from Invitrogen.(Ciphergen Biosystems)
Publication:Instrument Business Outlook
Article Type:Brief Article
Geographic Code:1USA
Date:Jun 30, 2001
Previous Article:Early Warnings: Pharmaceutical R&D and Instrument Spending.
Next Article:Waters Cuts Second Quarter Growth Forecast.

Related Articles
Amersham Acquires High-Pressure Process Chromatography Company.
Stock market rally lifts IBO stock indices.
Products. (Random Samples).
The preliminary IBO Laboratory Instrument Sales Index.
Instrument sales index shows slight growth in second quarter.
The bottom line.
The bottom line.
Pall to acquire Ciphergen's process chromatography business.
The bottom line.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |